Scil Technology GmbH Report issue

For profit Phase 2
Founded: Planegg Germany (2003)
Status: Acquired by Henry Schein, Inc (2015) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2005
NCT00520377
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

scil animal care

Active Ingredients

Drugs in Phase 2 Trials (4)

bone autograft (1 trial)

calcium phosphate (1 trial)

md05 (1 trial)

recombinant human gdf-5 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alveolar Bone Loss (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4